The tumor microenvironment: A double-edged sword: Editorial

International Journal of Radiation Oncology Biology Physics

Volumn 42, Issue 4, 1998, Pages 697-699

  Siemann, D W ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

CANCER RADIOTHERAPY; CANCER RESISTANCE; CELL SURVIVAL; CHEMICAL MODIFICATION; CONFERENCE PAPER; DRUG PENETRATION; HYPOXIA; PRIORITY JOURNAL; SOLID TUMOR; TISSUE OXYGENATION; TUMOR BLOOD FLOW; TUMOR SUPPRESSOR GENE;

EID: 0031774009     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00336-8     Document Type: Conference Paper

References (33)

1. B.A Warren The vascular morphology of tumors H.I Petersen Tumor blood circulation 1979 CRC Press Boca Raton, FL 1 47
2. P Vaupel F Kallinowski P Okunieff Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors A review Cancer Res 49 1989 6449 66465
3. R.H Thomlinson L.H Gray The histological structure of some human lung cancers and the possible implications for radiotherapy Brit J Cancer 9 1955 539 549
4. R.M Sutherland W.A Ausserrer B.J Murphy Tumor hypoxia and heterogeneity challenges and opportunities for the future Sem Radiat Oncol 6 1996 59 70
5. J Overgaard M.R Horsman Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and radiosensitizers Sem Radiat Oncol 6 1996 10 21
6. D.W Siemann M.R Horsman D.J Chaplin Modification of oxygen supply M Molls P Vaupel Medical radiology blood perfusion and microenviroment of human tumors 1998 Springer-Verlag Heidelberg 209 217
7. R.E Durand Keynote address The influence of microenvironmental factors on the activity of radiation and drugs Int J Radiat Oncol Biol Phys 20 1991 253 258
8. D.W Siemann Modification of chemotherapy by nitroimidazoles Int J Radiat Oncol Biol Phys 10 1984 1585 1594
9. A.C Sartorelli Therapeutic attack of hypoxic cells of solid tumors presidential address Cancer Res 8 1988 775 778
10. D.J Chaplin M.R Horsman M.J Trotter Therapeutic significance of microenviroment factors M Molls P Vaupel Medical radiology blood perfusion and microenviroment of human tumours 1998 Springer-Verlag Heidelberg 133 143
11. I.F Tannock The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumor Brit J Cancer 22 1968 258 273
12. D.W Siemann C.A Hinchman Potentiation of cisplatin activity by the bioreductive agent tirapazamine Radiother Oncol 47 1998 215 220
13. J.M Brown The potential benefit of hypoxic cytotoxins in radio-oncology M Molls P Vaupel Medical radiology blood perfusion and microenvironment of human tumors 1998 Springer-Verlag Heidelberg 219 229
14. A.J Giaccia Hypoxic stress proteins survivial of the fittest Sem Radiat Oncol 6 1996 46 58
15. T Graeber C Osmanian T Jacks Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors Nature 379 1996 88 91
16. H.B Stone J.M Brown T.L Phillips Oxygen in human tumors Correlations between methods of measurement and response to therapy Radiat Res 136 1993 422 434
17. M.R Horsman A.A Khalil M Nordsmark The use of oxygen electrodes to predict radiobiological hypoxia in tumours P Vaupel D.K Kelleher M Gunderoth Tumor oxygenation 1995 Gustaf Fischer Verlag Stuttgart 49 57
18. M Hoeckel K Schlenger M Mitze Hypoxia and radiation ratio response in human tumors Sem Radiat Oncol 6 1996 3 9
19. D.M Brizel G.L Rosner J.M Harrelson Pretreatment oygenation profiles of human soft tissue sarcomas Int J Radiat Oncol Biol Phys 30 1994 635 642
20. P.L Olive R.E Durand Detecting hypoxic cells in murine tumor using the comet assay J Natl Cancer Inst 85 1992 707 711
21. R.J Hodgkiss G Jones A Long Flow cytometric evaluation of hypoxic cells in solid experimental tumors using fluorescence immunodetection Brit J Cancer 63 1991 119 125
22. G.E Arteel R.G Thurman J.M Yates Evidence that hypoxia markers detect oxygen gradients in liver Pimonidazole and retrograde perfusion of rat liver Brit J Cancer 72 1995 889 895
23. C.J Koch M.L Evans E.M Lord Oxygen dependence of cellular uptake of EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide] analysis of drug adducts by fluorescent antibodies vs bound radioactivity Brit J Cancer 82 1997 869 874
24. E.O Aboagye R.J Maxwell A.B Kelson Preclinical evaluation of the fluorinated 2-nitroimidazole N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR-4554) as a probe for the measurement of tumor hypoxia Cancer Res 57 1997 3314 3318
25. L Kwock M Gill H.L McMurry Evaluation of a fluorinated 2-nitroimidazole binding to hypoxic cells in tumor-bearing rats by 19F magnetic resonance spectroscopy and immunohistochemistry Radiat Res 129 1992 71 78
26. W.J Koh J.S Rasey M.L Evans Imaging of hypoxia in human tumors with [F-18] fluoromisonidazole Int J Radiat Oncol Biol Phys 22 1992 199 212
27. J.D Chapman E.L Engelhardt C.C Stobbe Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays Radioth Oncol 46 1998 229 237
28. G.E Adams I.J Stratford Hypoxia-mediated nitro-heterocyclic drugs in the radio- and chemotherapy of cancer Biochem Pharmacol 35 1986 71 76
29. G.U Dachs D.J Chaplin Microenvironmental control of gene expression Implications for tumor angiogenesis, progression, and metastasis Sem Radiat Oncol 8 1998 208 216
30. P Scott A.L Harris Current approaches to targeting cancer using antiangiogenesis therapies Cancer Treat Rev 20 1994 393 412
31. M.S O’Reilly T Boehm Y Shing Endostatin An endogenous inhibitor of angiogenesis and tumor growth Cell 88 1997 277 285
32. G.G Dark S.A Hill V.E Prise Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature Cancer Res 57 1997 1829 1834
33. S Cliffe M.L Taylor M Rutland Combining bioreductive drugs (SR 4233 or SN 23862) with the vasoactive agents flovane acetic acid or 5,6-dimethylxanthenone acetic acid Int J Radiat Oncol Biol Phys 29 1994 373 377